GE HealthCare Technologies Inc. Profile Avatar - Palmy Investing

GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. operates as a medical technology, pharmaceutical diagnostics, and digital solutions provider. Its products, services, and solutions enable clinicians to make informed decisions, improving patient care from diagnosis to the…
Medical - Healthcare Information Services
US, Chicago [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 67% Positive
Leverage & Liquidity 17% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 24.82 60.08 48.13
Graham Fair Price -2.04 17.31 17.68
PEG 35.72 -3.47 2.56
Price/Book 11.74 5.51 4.93
Price/Cash Flow 304.89 149.00 36.80
Prices/Earnings 25.04 27.29 21.82
Price/Sales 29.92 8.78 6.76
Price/FCF 304.89 149.00 36.80
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -1.28 0.41 0.41
Operating Margin -12.25 0.12 0.13
ROA -6.49 0.01 0.01
ROE 0.06 0.05 -10.64
ROIC 0.03 0.02 -13.46
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.02 -0.04 48.90
Dividends QOQ -0.07 0.07 4.39
EBIT QOQ 0.12 -0.22 85.32
EPS QOQ 0.09 -0.08 -7.87
FCF QOQ 0.68 -0.71 5.35
Revenue QOQ 0.08 -0.11 34.11
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 57.84 65.12 12.59
Days Sales Outstanding (DSO) 73.54 77.75 5.72
Inventory Turnover 1.56 1.38 -11.18
Debt/Capitalization 0.58 0.57 -2.44
Quick Ratio 0.75 0.74 -1.33
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 15.68 16.25 3.63
Cash 5.48 5.59 2.06
Capex -0.21 -0.32 -53.92
Free Cash Flow 2.10 0.60 -71.40
Revenue 11.44 10.20 -10.88
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.05 1.06 0.98
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 8.34 8.92 6.99
Naive Interpretation Member
06 - Financial Health · Bad
End of GEHCV's Analysis
CIK: - CUSIP: - LEI: - UEI: -
Secondary Listings